IC
Ikarian Capital Portfolio holdings
AUM
$494M
1-Year Est. Return
153.64%
1 Year Est. Return
+153.64%
AUM
$494M
AUM Growth
+$192M
(+64%)
Holding
157
Top Buys
| 1 | +$53M | |
| 2 | +$33.4M | |
| 3 | +$27.2M | |
| 4 |
PTC Therapeutics
PTCT
|
+$17.2M |
| 5 |
RAPT Therapeutics
RAPT
|
+$15.9M |
Top Sells
| 1 | +$21.6M | |
| 2 | +$18.5M | |
| 3 | +$17.9M | |
| 4 |
Cogent Biosciences
COGT
|
+$14.7M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$13.9M |
Sector Composition
| 1 | Healthcare | 99.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
United Therapeutics
UTHR
$20.9B
| – | – |
0
|
|
||
152
Vera Therapeutics
VERA
$2.72B
| – | – |
-14,096
|
|
||
|
VIGL
153
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-31,360
|
|
||
|
VRNA
154
DELISTED
Verona Pharma
VRNA
| – | – |
-146,831
|
|
||
155
State Street SPDR S&P Biotech ETF
XBI
$8.17B
| – | – |
0
|
|
||
|
TECX
156
Tectonic Therapeutic
TECX
$398M
| – | – |
-163,696
|
|
||
|
TVRD
157
Tvardi Therapeutics
TVRD
$39.6M
| – | – |
0
|
|